Arbutus Biopharma Corp (ABUS)

Operating Income Growth

-500.81%

Quarterly · Period ending:

ABUS logo

ABUS Operating Income Growth

Year-over-year change vs the same period a year earlier

Latest reported-500.81%
ABUS Quarterly Operating Income YoY % (-2923.29% → -500.81%)
High-resolution chart · PNG

ABUS operating income growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Arbutus Biopharma Corp Operating Income Growth — Quarterly
Period endingOperating Income Growth
-500.8065%
587.9595%
45.1374%
61.32%
106.8943%
-78.9909%
32.8433%
0.5474%
-17.3946%
-11.1985%
8.0445%
-21.0376%
-30.3069%
-58.6751%
-8.492%
3.2432%
24.3161%
29.9949%
-27.575%
-20.97%
-41.8613%
-19.2363%
-25.0556%
83.3514%
35.9444%
31.0629%
22.8835%
-181.8757%
6.9446%
-3.6186%
71.9448%
-151.4228%
-13.1434%
-0.5793%
76.5968%
32.0316%
90.0204%
8.3997%
-2,089.4795%
67.3621%
-1,255.8889%
-10.9464%
-9.4073%
-749.474%
-52.8176%
-202.2155%
-338.3075%
-87.6973%
-213.4688%
-96.6019%
58.3683%
-102.3916%
-18.3968%
-14.7485%
-162.1968%
-11.1411%
32.128%
16.5632%
68.8621%
-152.6605%
5.362%
27.9361%
-189.1882%
227.1107%
-105.7856%
-151.4511%
2.3201%
8.6385%
62.5116%
-107.5468%
-3,080.0352%
-260.6192%
-2,923.2903%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.